Halozyme Therapeutics, Inc. (HALO): 8-K filed Sep 16, 2026

Form type

8-K

Filing date

Sep 16, 2026

Accession number

0001159036-26-000121

Filer

Halozyme Therapeutics, Inc. (CIK 1159036)